AUTOLOGOUS NEUTRALIZING ANTIBODIES PREVAIL IN HIV-2 BUT NOT IN HIV-1 INFECTION

被引:74
|
作者
BJORLING, E
SCARLATTI, G
VONGEGERFELT, A
ALBERT, J
BIBERFELD, G
CHIODI, F
NORRBY, E
FENYO, EM
机构
[1] KAROLINSKA INST, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[2] NATL BACTERIOL LAB, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[3] NATL BACTERIOL LAB, DEPT IMMUNOL, S-10521 STOCKHOLM, SWEDEN
关键词
D O I
10.1006/viro.1993.1160
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 2 (HIV-2) has been reported to be less pathogenic than HIV-1. We have investigated the capacity of sera from nine HIV-2-infected individuals to neutralize their own autologous virus. All nine HIV-2-infected individuals neutralized autologous virus with titers ranging between 20 and 320. In contrast, we have previously reported that most HIV-1-infected individuals lack such antibodies. The difference between HIV-1 and HIV-2 infection was statistically significant (P < 0.0002, Pearson test) and the difference in neutralizing antibody prevalence may explain the faster disease progression in HIV-1-infected individuals than in HIV-2-infected individuals. © 1993 Academic Press, Inc.
引用
收藏
页码:528 / 530
页数:3
相关论文
共 50 条
  • [31] GENETIC-ANALYSIS OF HIV-1, HIV-2 AND HIV-1/HIV-2 MIXED INFECTIONS IN INDIA
    DIETRICH, U
    GREZ, M
    VONBRIESEN, H
    MAHAMBRE, G
    MANIAR, J
    RUBSAMENWAIGMANN, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S109 - S109
  • [32] Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection
    Stiegler, G
    Katinger, H
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 757 - 759
  • [33] Role of Broadly Neutralizing Antibodies in the Controlling of HIV-1 Infection
    Yildirmak, Taner
    [J]. KLIMIK JOURNAL, 2019, 32 (02) : 112 - 116
  • [34] Neutralizing antibodies for HIV-1 prevention
    Julg, Boris
    Barouch, Dan H.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) : 318 - 324
  • [35] HIV-2 INFECTION IN HIV-1 INDETERMINATE SERA IN SPAIN - REPLY
    JOSEPH, JM
    MYERS, RA
    PATEL, JD
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (03): : 324 - 324
  • [36] Dual HIV-1 and HIV-2 infection in a West African infant
    Van Der Sande, MAB
    Luong, TN
    Van Der Loeff, MFS
    Sabally, S
    Aveika, AA
    Corrah, T
    Sarge-Njie, R
    Kaye, S
    Whittle, HC
    [J]. ANNALS OF TROPICAL PAEDIATRICS, 2004, 24 (03): : 277 - 278
  • [37] DISCRIMINATION OF HIV-1 AND HIV-2 INFECTION BASED ON RECOMBINANT IMMUNOBLOTS
    BAUR, A
    ERLWEIN, O
    EHRMANN, U
    JAHN, G
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1989, 24 (03) : 275 - 283
  • [38] ABSENCE OF HIV-2 IN SPANISH GROUPS AT RISK FOR HIV-1 INFECTION
    ESTEBANEZ, P
    SARASQUETA, C
    RUAFIGUEROA, M
    FITCH, K
    EUGENIA, PV
    VARELA, JM
    CONTRERAS, G
    CASADO, C
    PEREZ, L
    NAJERA, R
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (04) : 423 - 424
  • [39] Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection
    Esbjornsson, Joakim
    Mansson, Fredrik
    Kvist, Anders
    Isberg, Per-Erik
    Nowroozalizadeh, Salma
    Biague, Antonio J.
    da Silva, Zacarias J.
    Jansson, Marianne
    Fenyo, Eva Maria
    Norrgren, Hans
    Medstrand, Patrik
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03): : 224 - 232
  • [40] Effect of HIV-2 infection on HIV-1 disease progression and mortality
    Esbjornsson, Joakim
    Mansson, Fredrik
    Kvist, Anders
    Isberg, Per-Erik
    Nowroozalizadeh, Salma
    Biague, Antonio J.
    da Silva, Zacarias J.
    Jansson, Marianne
    Fenyo, Eva Maria
    Norrgren, Hans
    Medstrand, Patrik
    [J]. AIDS, 2014, 28 (04) : 614 - 615